On May 28, 2015, a panel from the American Medical Informatics Association (“AMIA”) published an eleven-page “Report of the AMIA EHR 2020 Task Force on the Status and Future Direction of EHRs.”  Recognizing that current problems in EHR use “are complex” and that “[s]olving these problems will require regulatory stability, the development of an acceptable threshold ‘barrier to entry’ into the EHR marketplace, and a supportive national policy,” the report outlines ten “near-term strategies” to address challenges with EHR systems.   

The report’s recommendations cover five areas, which should be “a focus” over the next six to twelve months.  These areas are:

  1. Simplify and speed documentation;
  2. Refocus regulation;
  3. Increase transparency and streamline certification;
  4. Foster innovation; and
  5. “The EHR in 2020 must support person-centered care delivery.”

The recommendations include:

  1. Lessen the data entry burden on clinicians, by allowing relevant information to be entered by, for example, other members of the care team;
  2. Focus regulation on clarifying and simplifying certification procedures and meaningful use regulations, improving data exchange and interoperability, cutting the need for duplicate data entry, and prioritizing patient outcomes;
  3. Improve flexibility and transparency in the EHR certification process to improve usability and safety and foster innovation;
  4. Use “public standards-based application programming interfaces and data standards that will enable EHRs to become more open to innovators, researchers, and patients”; and
  5. Integrate EHRs into the full social context of care.
Photo of Krysten Rosen Moller Krysten Rosen Moller

Krysten Rosen Moller practices in the areas of health care, litigation, pharmaceutical investigations, and white collar defense and investigations. Ms. Rosen Moller primarily helps pharmaceutical and medical device companies with internal investigations, and civil and criminal investigations by the DOJ, FDA, HHS, and…

Krysten Rosen Moller practices in the areas of health care, litigation, pharmaceutical investigations, and white collar defense and investigations. Ms. Rosen Moller primarily helps pharmaceutical and medical device companies with internal investigations, and civil and criminal investigations by the DOJ, FDA, HHS, and other agencies, relating to fraud, marketing, kickbacks, manufacturing practices, and false claims. Ms. Rosen Moller also provides advice on developments in, and compliance with, health care laws.